Latest Payments News

BlackRock Investment Management (Australia) Limited has updated its estimated cash distributions for the iShares Balanced ESG ETF and the iShares High Growth ESG ETF, providing investors with important timetable details and tax compliance reminders.

AuKing Mining advances its strategic acquisition of Orion Resources and the Cloncurry Gold Project while securing a $5 million loan facility and progressing exploration across multiple continents.

Aspen Group has upgraded its FY26 pre-tax earnings guidance by 6%, driven by strong rental income growth and development profits amid Australia's acute housing shortage. The company also announces a strategic acquisition of a new Sydney headquarters.

Bailador Technology Investments reported a robust FY25 with a 33% gross IRR from its private portfolio, $41 million deployed in new and follow-on investments, and a strong final dividend of 3.6 cents per share.

Alma Metals is advancing its Briggs Copper Project with a deep diamond drill hole underway and the scoping study nearing completion, supported by a Queensland Government grant and solid financial footing.

Renegade Exploration Limited has secured an option over the Fireball Ridge Gold-Silver Project in Nevada, marking its fifth project in the prolific Walker Lane Trend and setting the stage for renewed exploration activity.

Manhattan Corporation advances a high-resolution magnetic survey at its Hook Lake gold project in Nunavut while agreeing to sell its L3 Lithium Project in Nova Scotia for up to $1.34 million.

Latitude 66 has completed the sale of its 17.5% stake in the Greater Duchess Joint Venture to Carnaby Resources for A$6 million, eliminating debt and boosting funds for exploration.

Mayne Pharma has won a key legal battle against Cosette Pharmaceuticals, clearing the way for its acquisition scheme to proceed pending final approvals. Shareholders can expect the deal to move forward with payments scheduled soon.

Bannerman Energy Ltd reported a robust cash position of AUD 111.76 million at the end of September 2025, underpinning an estimated 13.5 quarters of operational funding despite ongoing exploration expenditures.

Aroa Biosurgery delivered a robust September quarter with strong cash flow and record sales of its Myriad product, while reaffirming its FY26 revenue and EBITDA guidance. The company also highlighted a promising US Medicare reimbursement proposal for its Symphony product.

Native Mineral Resources Holdings Limited reported a challenging quarter with negative operating cash flow but secured significant financing to support ongoing exploration activities. The company anticipates improved cash flow performance in coming months.